Safeguard Scientifics, Inc (NYSE:SFE) Sees Significant Drop in Short Interest
Safeguard Scientifics, Inc (NYSE:SFE) saw a significant decrease in short interest in August. As of August 31st, there was short interest totalling 531,900 shares, a decrease of 22.7% from the July 31st total of 688,100 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average daily trading volume, of 68,200 shares, the days-to-cover ratio is currently 7.8 days.
Institutional investors have recently modified their holdings of the company. Captrust Financial Advisors grew its holdings in shares of Safeguard Scientifics by 272.3% during the second quarter. Captrust Financial Advisors now owns 3,008 shares of the asset manager’s stock valued at $36,000 after buying an additional 2,200 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in Safeguard Scientifics by 227.9% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,033 shares of the asset manager’s stock worth $44,000 after acquiring an additional 2,803 shares during the period. Spears Abacus Advisors LLC purchased a new position in Safeguard Scientifics during the 2nd quarter valued at about $202,000. Morgan Stanley grew its stake in Safeguard Scientifics by 15.2% during the 2nd quarter. Morgan Stanley now owns 19,979 shares of the asset manager’s stock valued at $241,000 after acquiring an additional 2,630 shares in the last quarter. Finally, Salzhauer Michael increased its holdings in shares of Safeguard Scientifics by 29.1% in the 1st quarter. Salzhauer Michael now owns 20,405 shares of the asset manager’s stock valued at $221,000 after purchasing an additional 4,600 shares during the period. 67.98% of the stock is owned by institutional investors and hedge funds.
Separately, ValuEngine upgraded shares of Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a report on Thursday, August 8th.
Safeguard Scientifics (NYSE:SFE) last posted its quarterly earnings data on Thursday, August 8th. The asset manager reported $1.75 earnings per share for the quarter, topping the consensus estimate of ($0.85) by $2.60. On average, equities research analysts predict that Safeguard Scientifics will post 1.71 EPS for the current fiscal year.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Featured Story: What are high-yield dividend stocks?
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.